Ticker Details
Cytokinetics, Incorporated Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
IPO Date:	May 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$7.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 2.79%
Avg Daily Range (30 D):	$0.97 | 1.55%
Avg Daily Range (90 D):	$1.20 | 1.88%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	1.57M
Avg Daily Volume (90 D):	1.59M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	8,365
Avg Institutional Trade:	$3.39M
Avg Institutional Trade (30 D):	$5.03M
Avg Institutional Trade (90 D):	$4.41M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$7.39M
Avg Closing Trade (30 D):	$19.49M
Avg Closing Trade (90 D):	$16.55M
Avg Closing Volume:	179.25K

News

Mar 23, 2026 @ 5:17 PM Biohaven Stock Down 70% but One Fund's New $6 Mill... Source: Jonathan Ponciano

Mar 18, 2026 @ 8:00 PM Cytokinetics Announces Inducement Grants Under Nas... Source: Na

Mar 9, 2026 @ 6:18 PM Cytokinetics Insider Exercises Options Worth Over ... Source: Sara Appino

Feb 24, 2026 @ 9:00 PM Cytokinetics Reports Fourth Quarter 2025 Financial... Source: Cytokinetics, Incorporated

Feb 19, 2026 @ 8:30 AM Global Amyotrophic Lateral Sclerosis Therapeutics ... Source: Custom Market Insights

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-6.54	$-1.5	$-6.54
Diluted EPS	$-6.54	$-1.5	$-6.54
Revenue	$88.04M	$17.76M	$88.04M
Gross Profit
Net Income / Loss	$-784.96M	$-183.03M	$-784.96M
Operating Income / Loss	$-612.26M	$-178.37M	$-612.26M
Cost of Revenue
Net Cash Flow	$30.4M	$-102.95M	$30.4M
PE Ratio

Splits
Jun 25, 2013	1:6